Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-02-05 Sale | 2024-02-06 9:47 pm | ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER | 4,583 | $29.3 | $134,282 | 101,974 (Direct) | View |
2023-11-30 Sale | 2023-12-05 9:08 pm | ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER | 3,826 | $29.2 | $111,719 | 33,140 (Direct) | View |
2023-11-15 Sale | 2023-11-17 7:52 pm | ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER | 108,609 | $16.04 | $1,741,959 | 574,342 (Direct) | View |
2023-08-09 Sale | 2023-08-11 5:02 pm | ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER | 100,210 | $14.2 | $1,422,982 | 86,169 (Direct) | View |
2023-08-02 Sale | 2023-08-04 7:33 pm | ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER | 84,581 | $17.1 | $1,446,659 | 442,124 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-08-27 Option Award | 2024-08-27 7:51 pm | N/A 2034-08-26 | FibroBiologics Inc. | FBLG | Coen Stacy Ann Director | 5,000 | $0 | 5,000 (Direct) | View |
Ownership(A) | 2024-08-13 4:01 pm | N/A 2033-02-16 | FibroBiologics Inc. | FBLG | Coen Stacy Ann Director | 0 | $0 | 190,300 (Direct) | View |
Ownership | 2024-02-13 6:30 pm | N/A N/A | FibroBiologics Inc. | FBLG | Coen Stacy Ann Director | 0 | $0 | 7,500 (Direct) | View |
2024-02-12 Disposition | 2024-02-12 4:44 pm | N/A 2031-02-05 | ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER | 918,537 | $0 | 0 (Direct) | View |
2024-02-02 Exercise | 2024-02-06 9:47 pm | N/A N/A | ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER | 14,350 | $0 | 101,974 (Direct) | View |
2024-02-01 Option Award | 2024-02-05 9:26 pm | N/A N/A | ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER | 39,293 | $0 | 39,293 (Direct) | View |
2023-12-29 Exercise | 2024-01-03 5:51 pm | N/A N/A | ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER | 30,000 | $5.32 | 366,972 (Direct) | View |
2023-12-29 Exercise | 2024-01-03 5:51 pm | N/A 2032-02-04 | ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER | 30,000 | $0 | 366,972 (Direct) | View |
2023-12-29 Option Award | 2024-01-03 5:51 pm | N/A N/A | ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER | 367 | $16.01 | 366,972 (Direct) | View |
2023-11-15 Exercise | 2023-11-17 7:52 pm | N/A 2030-06-01 | ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER | 108,609 | $0 | 574,342 (Direct) | View |
2023-11-15 Exercise | 2023-11-17 7:52 pm | N/A N/A | ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER | 82,223 | $7.69 | 574,342 (Direct) | View |
2023-11-15 Exercise | 2023-11-17 7:52 pm | N/A N/A | ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER | 26,386 | $4.92 | 574,342 (Direct) | View |
2023-09-08 Exercise | 2023-09-11 4:08 pm | 2022-02-05 2031-02-05 | ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER | 26,006 | $0 | 195,976 (Direct) | View |
2023-09-08 Exercise | 2023-09-11 4:08 pm | N/A N/A | ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER | 26,006 | $7.69 | 195,976 (Direct) | View |
2023-08-09 Exercise | 2023-08-11 5:02 pm | 2021-06-01 2030-06-01 | ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER | 100,210 | $0 | 86,169 (Direct) | View |
2023-08-09 Exercise | 2023-08-11 5:02 pm | N/A N/A | ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER | 100,210 | $4.92 | 86,169 (Direct) | View |
2023-08-02 Exercise | 2023-08-04 7:33 pm | 2021-06-01 2030-06-01 | ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER | 84,581 | $0 | 442,124 (Direct) | View |
2023-08-02 Exercise | 2023-08-04 7:33 pm | N/A N/A | ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER | 84,581 | $4.92 | 442,124 (Direct) | View |
2023-06-30 Option Award | 2023-07-05 5:55 pm | N/A N/A | ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER | 3,792 | $4.05 | 10,960 (Direct) | View |
2023-02-03 Option Award | 2023-02-07 5:21 pm | N/A N/A | ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER | 286,900 | $0 | 286,900 (Direct) | View |
2022-05-20 Option Award | 2022-12-27 5:18 pm | 2022-05-20 2030-06-01 | ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER | 90,000 | $0 | 120,000 (Direct) | View |
2022-06-30 Option Award | 2022-07-05 4:33 pm | N/A N/A | ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER | 3,342 | $3.825 | 7,168 (Direct) | View |
2022-02-04 Option Award | 2022-02-08 5:26 pm | 2023-02-04 2032-02-04 | ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & Chief Business Officer | 333,465 | $5.32 | 333,465 (Direct) | View |
2021-12-31 Option Award | 2022-01-04 4:06 pm | N/A N/A | ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & Chief Business Officer | 1,496 | $5.6 | 3,826 (Direct) | View |
2021-06-30 Option Award | 2021-07-02 4:20 pm | N/A N/A | ImmunoGen Inc. | IMGN | Coen Stacy Ann Chief Business Officer | 2,330 | $5.52 | 2,330 (Direct) | View |
2021-02-05 Option Award | 2021-02-09 8:11 pm | 2022-02-05 2031-02-05 | ImmunoGen Inc. | IMGN | Coen Stacy Ann Chief Business Officer | 185,016 | $7.69 | 185,016 (Direct) | View |
2020-06-01 Option Award | 2020-06-04 1:09 pm | 2021-06-01 2030-06-01 | ImmunoGen Inc. | IMGN | Coen Stacy Ann Chief Business Officer | 260,000 | $4.92 | 260,000 (Direct) | View |